| |
 |
|
Class Information
Number: 514/167
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin d, etc.) doai
Description:
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7605145 |
Micronutrient formulations for treatment of diabetes mellitus |
Oct. 20, 2009 |
| 7572462 |
Peri-operative and peri-procedure nutritional supplementation |
Aug. 11, 2009 |
| 7566696 |
Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
Jul. 28, 2009 |
| 7563783 |
2-methylene-19-nor-(20S-24S)-1.alpha.,25-dihydroxyvitamin-D.sub.2 |
Jul. 21, 2009 |
| 7560123 |
Compositions and methods for nutrition supplementation |
Jul. 14, 2009 |
| 7560240 |
Method for monitoring gastrointestinal inflammation in persons with inflammatory bowel disease(IBD) |
Jul. 14, 2009 |
| 7541349 |
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone |
Jun. 2, 2009 |
| 7541348 |
2-methylene-19-nor-(20S)-1.alpha.-hydroxy-trishomopregnacalciferol |
Jun. 2, 2009 |
| 7538098 |
19-nor-vitamin D analogs with 1,2 or 3,2 heterocyclic ring |
May. 26, 2009 |
| 7534777 |
Des-C,D analogs of 1.alpha.,25-dihydroxy-19-norvitamin D.sub.3 |
May. 19, 2009 |
| 7534778 |
(20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
May. 19, 2009 |
| 7531527 |
2-Propylidene-19-nor-vitamin D compounds |
May. 12, 2009 |
| 7528122 |
Vitamin D analog--NEL, methods and uses thereof |
May. 5, 2009 |
| 7514469 |
Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent |
Apr. 7, 2009 |
| 7514442 |
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
Apr. 7, 2009 |
| 7511028 |
Use of bisphosphonates for otosclerosis |
Mar. 31, 2009 |
| 7511030 |
2-methylene-19-nor-(20S-24epi)-1.alpha.,25-dihydroxyvitamin D.sub.2 |
Mar. 31, 2009 |
| 7491711 |
Methods of treatment using 3-desoxy vitamin D3 analogs |
Feb. 17, 2009 |
| 7491712 |
Process for preparation of paricalcitol and intermediates thereof |
Feb. 17, 2009 |
| 7476404 |
Composition for treatment of bone loss |
Jan. 13, 2009 |
| 7470695 |
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
Dec. 30, 2008 |
| 7468372 |
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
Dec. 23, 2008 |
| 7468361 |
2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
Dec. 23, 2008 |
| 7449451 |
Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks |
Nov. 11, 2008 |
| 7435725 |
Oral compositions and methods for prevention, reduction and treatment of radiation injury |
Oct. 14, 2008 |
| 7399755 |
Formulations comprising multiple dietary and endogenously made antioxidants and B-vitamins and use of same |
Jul. 15, 2008 |
| 7390509 |
Compositions and methods for nutrition supplementation |
Jun. 24, 2008 |
| 7332482 |
Method for treating benign prostatic hyperplasia |
Feb. 19, 2008 |
| 7303771 |
Alfalfa sprout powder based supplement |
Dec. 4, 2007 |
| 7300925 |
2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
Nov. 27, 2007 |
| 7279180 |
Stable emulsions and dry powders of mixtures of fat-soluble vitamins, their preparation and use |
Oct. 9, 2007 |
| 7262224 |
Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof |
Aug. 28, 2007 |
| 7259143 |
Method of extending the dose range of vitamin D compounds |
Aug. 21, 2007 |
| 7256184 |
Treatment of aging disorders in humans |
Aug. 14, 2007 |
| 7244719 |
2-methylene-19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and its uses |
Jul. 17, 2007 |
| 7241752 |
17,20(E)-dehydro vitamin D analogs and their uses |
Jul. 10, 2007 |
| 7241751 |
2.alpha.-methyl-19-nor-(20S)-1.alpha.-hydroxy-bishomopregnacalciferol and its uses |
Jul. 10, 2007 |
| 7241749 |
2.alpha.-Methyl and 2.beta.-methyl analogs of 19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and their uses |
Jul. 10, 2007 |
| 7241748 |
17,20(Z)-dehydro vitamin D analogs and their uses |
Jul. 10, 2007 |
| 7241747 |
2-propylidene-19-nor-vitamin D compounds |
Jul. 10, 2007 |
| 7241750 |
2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses |
Jul. 10, 2007 |
| 7238681 |
2-Methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses |
Jul. 3, 2007 |
| RE39706 |
Crystalline form of a vitamin D analogue |
Jun. 26, 2007 |
| 7232810 |
2-methylene-19-nor-vitamin D2 compounds |
Jun. 19, 2007 |
| 7220739 |
Therapeutic application of pro-apoptotic benzodiazepines |
May. 22, 2007 |
| 7214670 |
Use of 2-methylene-19-nor-20(S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to increase the life expectancy of human beings |
May. 8, 2007 |
| 7214671 |
Use of 2-methylene-19-nor-20(S)-1.alpha.,25-dihydroxyvitamin D.sub.3 for the prophylaxis of bone diseases |
May. 8, 2007 |
| 7208484 |
Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol |
Apr. 24, 2007 |
| 7205286 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D.sub.3 and their uses |
Apr. 17, 2007 |
| 7205007 |
Peri-operative and peri-procedure nutritional supplementation |
Apr. 17, 2007 |
|
|
|
